AZ CEO Pascal Soriot recorded an interview with PharmaDispatch during his recent trip to Australia.
In the first of a two-part interview, he discusses the new AstraZeneca, his personal affinity with 'home' in Australia and how it 'breaks his heart' governments here have not done more to grow innovative industries.
AZ's Pascal Soriot: 'My Australia and the new AstraZeneca'
January 31, 2019 BioPharmaDispatch ExecutiveNews of the Day
Latest Video
New Stories
-
Amplia announces second confirmed complete response in ACCENT trial
June 19, 2025 - - Australian Biotech -
NZ Government expands access to melatonin and psilocybin
June 18, 2025 - - Latest News -
Imugene announces US patent allowance for onCARlytics
June 18, 2025 - - Australian Biotech -
Pilot study confirms adjunct NB-UVB needed to activate repigmentation in vitiligo
June 18, 2025 - - Australian Biotech -
One CSL innovation that allows for a direct and timely comparison
June 18, 2025 - - Latest News -
New survey reveals role of credit cards and borrowing in healthcare access
June 18, 2025 - - Latest News -
Montu pushes for national standards at Productivity Commission inquiry
June 17, 2025 - - Latest News